TELA compared with BVS: revenue, margins and what each company keeps, and the suppliers and customers both name

TELATELA Bio, Inc.

Mkt capRevenueRevenue

BVSBioventus Inc.

Mkt capRevenueRevenue

Compare

TELATELA Bio, Inc.

BVSBioventus Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TELA1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−15.05%—

BVS

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±19.9%▲+13.71%×0.69

May 6 '26±17.1%▲+2.25%×0.13

= impliedTELA realized, solidBVS realized, hatchedOne scale, both sides: full bar = 20%× = |realized| ÷ impliedSource: market data

Q1 FY26

±17.5%

▲+7.44%

×0.42

Nov 4 '25±18.0%▲+15.09%×0.84

TELATELA Bio, Inc.

0.86▼−7.07%· post 0.81

Mkt cap$36.4MRevenue$19MQ2 FY26Revenue$80MFY25

BVSBioventus Inc.

13.35▼−10.25%· post 13.28

ClosedOct 30 '26

Mkt cap$1.1BRevenue$153MQ2 FY26Revenue$568MFY25

Compare

ClosedOct 30 '26

TELATELA Bio, Inc.

BVSBioventus Inc.

0.86▼−7.07%post 0.81

Price

13.35▼−10.25%post 13.28

$36.4M

Mkt cap

$1.1B

Q2 FY26$19M

Revenue

$153MQ2 FY26

FY25$80M

Revenue

$568MFY25

TELA0.86▼−7.07%vsBVS13.35▼−10.25%ClosedOct 30 '26